These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6171884)

  • 21. Stimulation of the rat mesolimbic dopaminergic system produces a pressor response which is mediated by dopamine D-1 and D-2 receptor activation and the release of vasopressin.
    Cornish JL; van den Buuse M
    Brain Res; 1995 Dec; 701(1-2):28-38. PubMed ID: 8925292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The C-terminal fragment of substance P enhances dopamine release in nucleus accumbens but not in neostriatum in freely moving rats.
    Boix F; Huston JP; Schwarting RK
    Brain Res; 1992 Oct; 592(1-2):181-6. PubMed ID: 1280516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Locomotor activation induced in rodent by substance P and analogues. Blockade of the effect of substance P by met-enkephalin antiserum.
    Naranjo JR; Del Rio J
    Neuropharmacology; 1984 Oct; 23(10):1167-71. PubMed ID: 6084200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioural effects of substance P through dopaminergic pathways in the brain.
    Iversen SD
    Ciba Found Symp; 1982; (91):307-24. PubMed ID: 6183078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substance P-induced release of Met5-enkephalin from striatal and periaqueductal gray slices.
    Del Río J; Naranjo JR; Yang HY; Costa E
    Brain Res; 1983 Nov; 279(1-2):121-6. PubMed ID: 6196090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of substance P on rat gastrointestinal transit.
    Silkoff P; Karmeli F; Goldin E; Ewenson A; Gilon C; Chorev M; Laufer R; Selinger Z; Rachmilewitz D
    Dig Dis Sci; 1988 Jan; 33(1):74-7. PubMed ID: 2448096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substance-P antagonists: effect on spontaneous and drug-induced locomotor activity in the rat.
    Elliott PJ; Iversen SD
    Neuropharmacology; 1987 May; 26(5):419-22. PubMed ID: 2439936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of (pGlu-5, MePhe-8, Sar-9) substance P (5-11) (DiMe-C7) using a polyacrylamide resin and biological activity on guinea pig ileum and tracheal smooth muscle.
    Calas B; Michelot R; Lecaer JP; Cave A; Parello J; Potier P
    Int J Pept Protein Res; 1987 Feb; 29(2):170-6. PubMed ID: 2437066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional expression of c-fos in rat brain following stimulation of the ventral tegmental area.
    Cornish JL; van den Buuse M
    Neurosci Lett; 1996 Dec; 220(1):17-20. PubMed ID: 8977138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intra-raphe neurokinin-induced hyperactivity: effects of 5,7-dihydroxytryptamine lesions.
    Paris JM; Mitsushio H; Lorens SA
    Brain Res; 1989 Jan; 476(1):183-8. PubMed ID: 2464417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain.
    Hagan RM; Butler A; Hill JM; Jordan CC; Ireland SJ; Tyers MB
    Eur J Pharmacol; 1987 Jun; 138(2):303-5. PubMed ID: 2442006
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuronal sites mediating locomotor hyperactivity following central neurokinin agonist administration.
    Elliott PJ; Paris JM; Mitsushio H; Lorens SA
    Pharmacol Biochem Behav; 1990 Oct; 37(2):329-33. PubMed ID: 1706862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substance P and behavior: opposite effects of N-terminal and C-terminal fragments.
    Hall ME; Stewart JM
    Peptides; 1983; 4(5):763-8. PubMed ID: 6197702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of surfactant secretion from isolated Type II pneumocytes by substance P.
    Rice WR; Singleton FM
    Biochim Biophys Acta; 1986 Nov; 889(2):123-7. PubMed ID: 2430623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pressor responses to electrical and chemical stimulation of the rat brain A10 dopaminergic system.
    Cornish JL; van den Buuse M
    Neurosci Lett; 1994 Aug; 176(2):142-6. PubMed ID: 7530350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Place aversion induced by the substance P analogue, dimethyl-C7, is not state dependent: implication of substance P in aversion.
    Elliott PJ
    Exp Brain Res; 1988; 73(2):354-6. PubMed ID: 2463935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the mesolimbic dopamine system in cardiovascular homeostasis. Stimulation of the ventral tegmental area modulates the effect of vasopressin on blood pressure in conscious rats.
    van den Buuse M
    Clin Exp Pharmacol Physiol; 1998 Sep; 25(9):661-8. PubMed ID: 9750953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretreatment with fragments of substance-P or with cholecystokinin differentially affects recovery from sub-total nigrostriatal 6-hydroxydopamine lesion.
    Nikolaus S; Huston JP; Schwarting RK
    Neural Plast; 1999; 6(4):77-89. PubMed ID: 10714262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further evidence on the anxiogenic-like effect of substance P evaluated in the elevated plus-maze in rats.
    Duarte FS; Testolin R; De Lima TC
    Behav Brain Res; 2004 Oct; 154(2):501-10. PubMed ID: 15313039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dose-response analysis of intra-raphe tachykinin-induced hyperactivity.
    Paris JM; Lorens SA
    J Pharmacol Exp Ther; 1989 Oct; 251(1):388-93. PubMed ID: 2795467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.